Emergent BioSolutions (EBS) Asset Utilization Ratio (2011 - 2026)
Emergent BioSolutions' Asset Utilization Ratio was 0.63 in Q2 2026, up 5.5% from 0.60 a year earlier and up 23.2% from the prior quarter.
Powered by 
Analysis
Emergent BioSolutions (EBS) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
For FY2025, Asset Utilization Ratio at Emergent BioSolutions came in at 0.55, down 15.6% from FY2024.
- In earlier years, Asset Utilization Ratio was 0.65 in FY2024 (+54.5%), 0.42 in FY2023 (+15.2%), 0.36 in FY2022 (-39.9%) and 0.61 in FY2021 (+0.3%).
- The Q2 2026 figure marks the highest quarterly Asset Utilization Ratio since Q1 2025.
- Compared with a year earlier, Asset Utilization Ratio was higher in four of the last eight quarters, with an average decline of 1.3%.
- The best year-over-year quarter for Asset Utilization Ratio over five years was Q1 2024 (growth of 104.6%); the worst was Q1 2023 (a decline of 46.1%).
- Per Business Quant data, EBS's Asset Utilization Ratio in the three quarters before Q2 2026 was 0.51 (Q1 2026), 0.53 (Q4 2025) and 0.55 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,145.84 Bn | 1,114.43 Bn | 19.71 Bn | 0.62 |
| 2 | Johnson & Johnson | 622.91 Bn | 541.44 Bn | 17.26 Bn | 0.49 |
| 3 | AbbVie | 510.98 Bn | 484.09 Bn | 12.70 Bn | 0.47 |
| 4 | Merck | 366.52 Bn | 320.90 Bn | 12.21 Bn | 0.52 |
| 5 | Novartis Ag | 297.50 Bn | 261.49 Bn | 11.24 Bn | 0.46 |
| 6 | Astrazeneca | 261.55 Bn | 235.23 Bn | 12.86 Bn | 0.51 |
| 7 | Amgen | 234.77 Bn | 190.17 Bn | 7.24 Bn | 0.40 |
| 8 | Gilead Sciences | 193.63 Bn | 167.83 Bn | 6.22 Bn | 0.58 |
| 9 | Pfizer | 172.17 Bn | 118.81 Bn | 10.94 Bn | 0.31 |
| 10 | Emergent BioSolutions | 322.24 Mn | -428.66 Mn | 137.20 Mn | 0.63 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.63 |
| Mar 31, 2026 | 0.51 |
| Dec 31, 2025 | 0.53 |
| Sep 30, 2025 | 0.55 |
| Jun 30, 2025 | 0.60 |
| Mar 31, 2025 | 0.69 |
| Dec 31, 2024 | 0.73 |
| Sep 30, 2024 | 0.75 |
| Jun 30, 2024 | 0.66 |
| Mar 31, 2024 | 0.65 |
| Dec 31, 2023 | 0.56 |
| Sep 30, 2023 | 0.54 |
| Jun 30, 2023 | 0.42 |
| Mar 31, 2023 | 0.32 |
| Dec 31, 2022 | 0.37 |
| Sep 30, 2022 | 0.54 |
| Jun 30, 2022 | 0.57 |
| Mar 31, 2022 | 0.59 |
| Dec 31, 2021 | 0.61 |
| Sep 30, 2021 | 0.56 |
API Access
Emergent BioSolutions Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=EBS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "EBS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=EBS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();